Therapeutic effect of Metadate in ADHD patients with somatic symptoms

Not Applicable

Active, not recruiting

• Conditions: Mental and behavioral disorders

• Registration Number: KCT0003866
• Lead Sponsor: Chung-Ang Univerisity Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 December 2019

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: Male
• Target Recruitment: 30

Inclusion Criteria

1) ADHD with somatic symptoms
? Attention deficit and hyperactivity disorder via Structured Clinical Interview for DSM-5 (SCID-5-CV)
? 13 to 45 years old
? Did not take psychostimulant including Methylphenidate before the initial evaluation
? Having somatic symptoms based on the somatosensory amplification scores (SSAS) over 30

2) ADHD without somatic symptoms
? Attention deficit and hyperactivity disorder via Structured Clinical Interview for DSM-5 (SCID-5-CV)
? 13 to 45 years old
? Did not take psychostimulant including Methylphenidate before the initial evaluation
? Not having any somatic symptoms last 20 days

Exclusion Criteria

? history of other psychiatric disorders diagnosed on the basis of SCID-5-CV or severe medical conditions
? BDI scores over 16
? History of drug abuse
? History of seizures, head trauma or organic brain lesions
? Claustrophobia

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
In fMRI, the functional connectivity between the anterior default mode network, posterior default mode network and attention network

Secondary Outcome Measures

Name	Time	Method
Korean version of Dupaul’s ADHD Rating Scale (K-ARS);Somato-Sensory Amplification Scale (SSAS);Beck depressive inventory (BDI);Beck Anxiety Inventory (BAI)